Emily Brown, John P H Wilding, Thomas M Barber, Uazman Alam, Daniel J Cuthbertson
It is available for purchase on resbiotic.com , and looks forward to introducing the product to likeminded brands at Expo West 2025
Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets
This is a 6.75 fold increased in percent weight loss from highest dose to placebo, compared to the 5.9 fold increase seen in the STEP-1 trial
Patients should inform their procedural and anesthesia teams if they take GLP-1 or dual incretin therapy, including Ozempic, Wegovy, Rybelsus, Trulicity, Victoza, Saxenda, Mounjaro, or Zepbound
Based on studies of branded medications in non-diabetics with obesity, or with overweight plus a weight-related condition, with diet and exercise